Skye Bioscience concludes merger with Emerald Health Therapeutics and unveils goals for 2022 and 2023
Skye Bioscience says Emerald Health Therapeutics shareholders approve integration plan of arrangement; gets regulatory approval to begin first-in-human clinical study
Skye Bioscience signs agreement to merge with Emerald Health Therapeutics
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
Emerald Health Therapeutics Announces Chief Financial Officer Transition
Emerald Health Therapeutics, Inc. (EMHTF) CEO Riaz Bandali on Q2 2021 Results - Earnings Call Transcript
Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update
Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET
Emerald Health Therapeutics Hires VP Sales & Marketing
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
Emerald Health Therapeutics Retains Listing Agent to Sell Previously-Closed Greater Vancouver Cannabis Cultivation Facility
Emerald Health Therapeutics Licenses New Proprietary Cannabis Dried Flower Format Patent for use in United States
Emerald Health Therapeutics Appoints Moe Jiwan as Chief Operating Officer
Emerald Health Therapeutics, Inc. (EMHTF) CEO Riaz Bandali on Q4 2020 Results - Earnings Call Transcript
Emerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate Update
Emerald Health Therapeutics Confirms Effective Listing Date on Canadian Securities Exchange
Emerald Health Therapeutics Establishes Partnership with Spanish Greenhouse Grower for GMP-Certified Cannabis
Emerald Health Therapeutics to Close Greater Vancouver Production Facility
Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans
Emerald Health Therapeutics Promotes Two Executives to Senior Roles
9 Penny Stocks to Buy If You Can Stomach Risk
Emerald Health Therapeutics Settles Outstanding Amounts
Emerald Health Therapeutics' Partner STENOCARE Makes First Delivery of Medical Cannabis Oil to Swedish Patients
2 Pot Stocks to Sell Before 2021
Emerald Health Therapeutics Introduces High Potency SYNC(TM) 100 CBD Oil
Emerald Health Therapeutics Terminates Agreement for Sale of Quebec Cannabis Business
Emerald Health Therapeutics, Inc. (EMHTF) CEO Riaz Bandali on Q3 2020 Results - Earnings Call Transcript
Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest & Achieves Pivotal Milestone in Transforming its Business